Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 366 of 5804
-
New drug combo aims to keep bladder cancer from coming back
Disease control Recruiting nowThe purpose of this study is to learn about the safety and effects of the study medicine (Disitamab Vedotin) in people with non-muscle invasive bladder cancer. This study is seeking participants whose bladder cancer is still in early stages, has not spread outside of the bladder,…
Phase: PHASE3 • Sponsor: Fudan University • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New tool could guide surgery timing for tough liver cancer
Disease control Not yet recruitingThis project aims to conduct a prospective, multicenter, randomized controlled clinical trial. The study plans to enroll 270 patients with locally advanced iCCA who have successfully undergone GOLP conversion therapy. Participants will be randomized at a 1:2:2 ratio into three ar…
Phase: NA • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Real-time DNA test during brain surgery could help remove more cancer
Diagnosis Not yet recruitingThis is a single-site, single-arm, prospective, interventional cohort study using intraoperative ultra-rapid droplet digital polymerase chain reaction (UR- ddPCR) to assess residual IDH1-mutant tumor at the end of surgical resection and, if positive, guide additional resection in…
Phase: NA • Sponsor: NYU Langone Health • Aim: Diagnosis
Last updated Jun 27, 2026 07:55 UTC
-
New hope for IBD patients: IL-23 blocker aims for Steroid-Free remission
Disease control Recruiting nowPatients diagnosed with moderate to severe CD or UC by the end of the study period were selected. After obtaining informed consent, treatment with infliximab-based drugs was initiated. Basic patient information and medical history were collected. The treatment process was followe…
Phase: PHASE4 • Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New surgery aims to stop lymphedema before it starts
Prevention Recruiting nowImmediate lymphatic reconstruction (ILR) is a novel surgical approach performed at the time of initial lymph node dissection with the goal of preventing lymphedema.(Chang et al. 2020) It involves the identification of lymphatic channels that are transected after lymph node dissec…
Sponsor: University of Chicago • Aim: Prevention
Last updated Jun 27, 2026 08:04 UTC
-
Timing is everything: new trial tests surgery before or after immunotherapy for kidney cancer
Disease control Not yet recruitingThe goal of this clinical trial is to learn whether the timing of surgery (cytoreductive nephrectomy) improves outcomes when combined with immunotherapy (ipilimumab and nivolumab) in adults with metastatic clear cell renal cell carcinoma. The main questions this study aims to an…
Phase: NA • Sponsor: Seoul National University Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New targeted pill may keep ALK lung cancer in check after standard treatment
Disease control Not yet recruitingThe PACIFIC study established the standard of care for immunotherapy consolidation after chemoradiotherapy (CRT) in patients with unresectable stage III non-small cell lung cancer (NSCLC). However, its benefit is limited in patients with driver gene mutations. The LAURA study est…
Phase: PHASE2 • Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Heart failure and AF: which procedure works best?
Disease control Not yet recruitingAtrial Fibrillation (AF) and Heart Failure (HF) are colliding global cardiovascular epidemics, individually impairing quality of life and cardiac performance, as well as increasing the risk of hospitalisation and mortality. When AF and HF co-exist, disease progression accelerates…
Phase: PHASE4 • Sponsor: University of British Columbia • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New drug aims to shield heart and kidneys from major events
Disease control Recruiting nowThe purpose of this study is to measure cardiovascular outcomes with orforglipron compared with placebo in participants with atherosclerotic cardiovascular disease (ASCVD) and/or chronic kidney disease (CKD). Participation in the study will last about 5 years.
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
New Immunotherapy-Chemo cocktail aims to boost cervical cancer survival
Disease control Not yet recruitingThis is a single-arm, phase II clinical trial evaluating the efficacy and safety of neoadjuvant Ivonescimab combined with paclitaxel and cisplatin (TP regimen), followed by concurrent chemoradiotherapy, in patients with high-risk, locally advanced cervical cancer (FIGO stage III-…
Phase: PHASE2 • Sponsor: Women's Hospital School Of Medicine Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New combo therapy targets blood cancer relapse
Disease control Not yet recruitingThis is a French multicenter open label non-randomized Phase II trial evaluating the efficacy and tolerance of a combination of oral zanubrutinib and BGB-11417 in subjects aged 18 years and older with previously treated Waldenström macroglobulinemia (WM) who require therapy accor…
Phase: PHASE2 • Sponsor: French Innovative Leukemia Organisation • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
AI eye test could spot Alzheimer's early
Diagnosis Not yet recruitingThe purpose of this study is to test the use of a screening tool to detect changes in the eye that are associated with Alzheimer's disease in adult participants with memory issues. For each participant, the study will last up to one month and requires one visit to the research si…
Sponsor: Eli Lilly and Company • Aim: Diagnosis
Last updated Jun 27, 2026 08:00 UTC
-
New hope for hard-to-treat colon cancer: drug combo tested in clinical trial
Disease control Not yet recruitingThis study is an investigator-initiated, prospective, multicenter, randomized, controlled, open-label, non-inferiority trial designed to evaluate the efficacy and safety of trifluridine/tipiracil plus fruquintinib versus trifluridine/tipiracil plus bevacizumab in the treatment of…
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Radioactive seeds aim to boost Chemo's punch against breast cancer
Disease control Not yet recruitingThis study is an open-label, controlled, multicenter phase III clinical trial designed to evaluate whether the use of iodine-125 radioactive seed markers can improve treatment response for patients with early or locally advanced breast cancer undergoing neoadjuvant therapy. Neoa…
Phase: PHASE3 • Sponsor: Pengfei Qiu • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
New combo may boost stem cell harvest for myeloma patients
Disease control Recruiting nowThis is a randomized, double-blinded, placebo-controlled, multi-center phase Ⅲ bridging clinical study designed to evaluate the efficacy, safety, and pharmacokinetic and pharmacodynamic profiles of Motixafortide (BL-8040) + G-CSF vs placebo + G-CSF mobilized hematopoietic stem ce…
Phase: PHASE3 • Sponsor: Guangzhou Gloria Biosciences Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New hope for rare liver disease: phase 3 trial of CS0159 launches
Disease control Recruiting nowA Randomized, Double-Blind, Placebo-controlled, Phase III Study to Evaluate the Efficacy and Safety of CS0159 in Patients with Primary Biliary Cholangitis (PBC) with inadequate response or intolerance to ursodeoxycholic acid (UDCA).
Phase: PHASE3 • Sponsor: Cascade Pharmaceuticals, Inc • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
New targeted drug shows promise for Hard-to-Treat gynecologic cancers
Disease control Not yet recruitingThis study is a single-arm, open-label, multicenter Phase IIa trial designed to evaluate the efficacy, safety, and pharmacokinetic profile of BRY812 for Injection in patients with LIV-1-positive advanced gynecological malignancies. The study comprises two cohorts. For Cohort 1 (o…
Phase: PHASE2 • Sponsor: BioRay Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New ventilator method may save fragile preemies from breathing tubes
Disease control Recruiting nowMany extremely premature infants require immediate help with breathing after birth. Positive pressure ventilation (PPV) using a device called a T-piece resuscitator is a common method. PPV is needed to establish proper lung function, improve gas exchange, and encourage the infant…
Phase: NA • Sponsor: Michelle Baczynski • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
HIV counselors lead new push to offer prevention pills at family planning visits
Prevention Recruiting nowThis is a cluster randomized, stepped wedge implementation study to introduce HIV testing services (HTS) counselor-led PrEP care in public health clinics in Kenya.
Phase: NA • Sponsor: University of Washington • Aim: Prevention
Last updated Jun 27, 2026 14:00 UTC
-
Could a watchful software save ICU patients from organ failure?
Disease control Recruiting nowThe study will compare ICU sub-units, those with additional support of a clinician awareness system, ICU Beacon, and those receiving the standard of care. The win-ratio composite outcome will be assessed by comparing patients by study group and stratified by APACHE score at admis…
Sponsor: ETH Zurich • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC